Form D · Other

Medstatix, LLC

Lancaster, PA · CIK 0001618951

Offering snapshot reported Oct 29, 2015 · SEC filing

Reported sold
$700K
Offering amount: $700K
Investors reported
2
Form D · investor count
Minimum accepted
$200K
Reported outside-investor minimum
First sale
Oct 27, 2015
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 29, 2015Initial$700,000No comparison2SEC filing
Oct 17, 2014Initial$1,525,000No comparison2SEC filing

Offering details

Securities
Debt
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-250321

Source: Form D, filed Oct 29, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Essam Abadir Director
Scott Haiges Director
Kimberly Ireland Executive
David Kennedy Director, Executive
Jeffrey Lehman Director
William Spire Director
Peter West Executive

Issuer details

Industry: Other (See others in industry)

Address:
100 N. Queen Street Fl3
Lancaster, PA, 17603